To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SPRYD4TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
115 supporting clones for gene SPRYD4 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB041397 testis .a 1 to 551 2 to 552   tiling clone, capped   551/551
(100 %)
2 diff
(99.7 %id)
NM_207344.3   .a 30 to 2132 1 to 2103 M50T RefSeq, AAA   2103/2103
(100 %)
1 diff
(100.0 %id)
DA033329   .a 31 to 553 2 to 525   capped   522/524
(99 %)
2 diff
(99.7 %id)
DA865943 Prostate .a 31 to 597 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA004825   .a 68 to 583 2 to 519   capped   518/518
(100 %)
4 diff
(99.3 %id)
DA638321 Liver .a 68 to 621 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
CB135999 Liver .a 69 to 547 1 to 479       479/479
(100 %)
1 diff
(99.8 %id)
AF451989 brain .a 73 to 1169 1 to 1097 M50T AAA   1097/1097
(100 %)
8 diff
(99.3 %id)
BI561650 testis .a 73 to 924 1 to 849 M50T L207P     849/851
(99 %)
27 diff
(96.9 %id)
BI544304 brain, hippocampus .a 75 to 712 1 to 637       639/637
(100 %)
8 diff
(98.8 %id)
TI_44350615   .a 77 to 924 127 to 971 M50T L207P     845/973
(86 %)
23 diff
(97.7 %id)
CN359518 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 78 to 708 23 to 652       630/652
(96 %)
1 diff
(99.9 %id)
AL832247 human endometrium carcinoma cell line .a 79 to 2132 1 to 2056 G29D M50T tiling clone, available from DKFZ, AAA   2056/2056
(100 %)
4 diff
(99.9 %id)
BM146509 leukopheresis .a 79 to 526 1 to 448       448/448
(100 %)
16 diff
(96.5 %id)
TI_44000340   .a 80 to 712 90 to 721       634/721
(87 %)
2 diff
(99.8 %id)
DA042547 bladder .a 81 to 648 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
DA070329 cerebellum .a 81 to 583 2 to 503   capped   502/502
(100 %)
2 diff
(99.7 %id)
DA258030 caudate nucleus .a 81 to 553 2 to 474   capped   473/473
(100 %)
3 diff
(99.4 %id)
DA383878 thalamus .a 81 to 629 2 to 551   capped   550/550
(100 %)
3 diff
(99.5 %id)
DA718008   .a 81 to 583 2 to 507   capped   506/509
(99 %)
6 diff
(98.9 %id)
DB188612 liver, tumor tissue .a 81 to 647 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
BU958893 mixed (pool of 40 RNAs) .a 86 to 633 1 to 549       549/800
(68 %)
14 diff
(98.3 %id)
BU180179 ductal carcinoma, cell line, Pancreas .a 88 to 842 1 to 763 M50T     763/914
(83 %)
12 diff
(98.7 %id)
BF210970 bone marrow, from chronic myelogenous leukemia .a 89 to 761 1 to 662 F5L A6H R7V S8L L9C ...     662/906
(73 %)
23 diff
(97.5 %id)
CB145346 Liver .a 89 to 630 1 to 542       542/542
(100 %)
2 diff
(99.7 %id)
BG435077 placenta .a 90 to 681 1 to 594       594/594
(100 %)
4 diff
(99.4 %id)
BG570988 placenta .a 90 to 862 1 to 772 K37I T38N A39R H40P S41Q ...     772/772
(100 %)
38 diff
(95.1 %id)
BI461527 testis .a 90 to 930 1 to 832 M50T N137T E138R A140P P141Q ...     832/927
(89 %)
38 diff
(96.0 %id)
BE242614 leukopheresis .a 90 to 497 1 to 408       408/408
(100 %)
3 diff
(99.3 %id)
BC020844 placenta .a 91 to 1168 1 to 1080 M50T available from MGC, AAA   1080/1080
(100 %)
3 diff
(99.8 %id)
DA040921 bladder .a 91 to 650 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
BY795353 eye .a 91 to 702 1 to 612       612/612
(100 %)
1 diff
(99.9 %id)
DA577060   .a 91 to 583 2 to 496   capped   495/495
(100 %)
2 diff
(99.6 %id)
BU958713 mixed (pool of 40 RNAs) .a 91 to 741 1 to 662 M50T V57M H174P P183S V184S ...     662/779
(84 %)
22 diff
(97.2 %id)
BM753863 stomach .a 91 to 531 1 to 441       441/441
(100 %)
5 diff
(98.9 %id)
BM835590 stomach .a 91 to 307 1 to 217       217/217
(100 %)
1 diff
(99.6 %id)
DA014855 adrenal gland .a 92 to 656 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DA057996 cerebellum .a 92 to 583 2 to 493   capped   492/492
(100 %)
2 diff
(99.6 %id)
DA072618 cerebellum .a 92 to 645 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DA166172 amygdala .a 92 to 672 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
DA170178 amygdala .a 92 to 634 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DA283548 corpus callosum .a 92 to 643 2 to 554   capped   553/553
(100 %)
2 diff
(99.7 %id)
DA370734 thalamus .a 92 to 583 2 to 493   capped   492/492
(100 %)
1 diff
(99.8 %id)
DA371472 thalamus .a 92 to 701 2 to 612   capped   611/611
(100 %)
2 diff
(99.7 %id)
DA425993 colon .a 92 to 663 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
DA427919 colon .a 92 to 563 2 to 474   capped   473/473
(100 %)
1 diff
(99.8 %id)
DA486124 brain .a 92 to 647 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
DA565212 heart .a 92 to 628 2 to 539   capped   538/538
(100 %)
2 diff
(99.7 %id)
DA684077   .a 92 to 649 2 to 559   capped   558/561
(99 %)
4 diff
(99.3 %id)
DA815723   .a 92 to 668 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DA866895 Prostate .a 92 to 636 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA933867 Spleen .a 92 to 665 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
DA988217 synovial membrane tissue from rheumatioidarthritis .a 92 to 656 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DB001330 breast, tumor tissue .a 92 to 652 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
DB008373 cervix, tumor tissue .a 92 to 553 2 to 463   capped   462/462
(100 %)
1 diff
(99.8 %id)
DB049285 testis .a 92 to 652 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DB110035 thymus .a 92 to 662 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DB178905 kidney, tumor tissue .a 92 to 655 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
AK291920   .a 93 to 1038 1 to 948 M50T     948/948
(100 %)
3 diff
(99.7 %id)
BX647957 human endometrium carcinoma cell line .a 93 to 2132 1 to 2040 M50T available from DKFZ, AAA   2040/2040
(100 %)
3 diff
(99.9 %id)
DA545100   .a 93 to 662 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA019440   .a 94 to 583 2 to 492   capped   491/491
(100 %)
1 diff
(99.8 %id)
DA902787   .a 94 to 644 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DA749459   .a 95 to 656 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
DA101572 cerebellum .a 96 to 636 2 to 544   capped   543/543
(100 %)
3 diff
(99.5 %id)
DA381632 thalamus .a 96 to 657 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA913413   .a 96 to 665 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DB056215 testis .a 96 to 659 2 to 566   capped   565/565
(100 %)
4 diff
(99.3 %id)
BM474269 leiomyosarcoma, uterus .a 98 to 879 12 to 799 M50T G200X     788/1047
(75 %)
16 diff
(98.5 %id)
BM047899 carcinoma, cell line, Prostate .a 99 to 775 1 to 684 S8G A39G M50T L56W L135S ...     684/908
(75 %)
25 diff
(97.3 %id)
BQ927408 carcinoma, cell line, Prostate .a 101 to 1018 1 to 927 M50T     927/927
(100 %)
18 diff
(98.1 %id)
BQ958414 carcinoma, cell line, Prostate .a 101 to 1024 1 to 932 M50T     932/933
(99 %)
19 diff
(98.0 %id)
BE890964 melanotic melanoma, skin .a 103 to 748 1 to 646 M50T     646/647
(99 %)
4 diff
(99.4 %id)
BX381622 Placenta Cot 25-normalized .a 104 to 1125 1 to 1013 M50T T197X     1013/1013
(100 %)
12 diff
(98.9 %id)
BQ438272 leiomyosarcoma, uterus .a 104 to 937 1 to 836 M50T     836/868
(96 %)
5 diff
(99.5 %id)
EL735643 mixed .a 105 to 687 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
T46853 Liver .a 105 to 520 1 to 428       428/435
(98 %)
19 diff
(95.7 %id)
TI_1948220751   .a 105 to 726 134 to 756       623/1417
(43 %)
6 diff
(99.6 %id)
TI_1948220920   .a 105 to 726 129 to 751       623/1392
(44 %)
11 diff
(99.3 %id)
TI_1948221093   .a 105 to 535 137 to 567       431/460
(93 %)
1 diff
(99.8 %id)
CR597464 Placenta Cot 25-normalized .a 106 to 2122 1 to 2017   tiling clone,   2017/2017
(100 %)
0 diff
(100 %id)
CR618271 Placenta Cot 25-normalized .a 106 to 1163 1 to 1058       1058/1058
(100 %)
0 diff
(100 %id)
CR624785 Placenta Cot 25-normalized .a 106 to 1135 1 to 1030       1030/1030
(100 %)
0 diff
(100 %id)
BX398291 Placenta Cot 25-normalized .a 106 to 1102 1 to 989       989/989
(100 %)
16 diff
(98.4 %id)
BX338532 Placenta Cot 25-normalized .a 106 to 1127 1 to 1006       1006/1006
(100 %)
21 diff
(98.0 %id)
BX381529 Placenta Cot 25-normalized .a 106 to 1026 1 to 926       926/952
(97 %)
37 diff
(96.2 %id)
BM796459 Ascites, stomach .a 106 to 486 1 to 381       381/381
(100 %)
3 diff
(99.3 %id)
CD673959 eye, lens .a 107 to 574 1 to 468       468/468
(100 %)
1 diff
(99.8 %id)
T60345 Liver .a 107 to 462 1 to 361       361/361
(100 %)
13 diff
(96.4 %id)
BE735357 choriocarcinoma, placenta .a 107 to 1004 20 to 909       890/1017
(87 %)
33 diff
(96.8 %id)
BQ050020 lymph, lymphoma, cell line .a 107 to 650 1 to 546       546/1370
(39 %)
11 diff
(99.2 %id)
BE872436 adenocarcinoma, colon .a 108 to 808 1 to 693       693/758
(91 %)
20 diff
(97.4 %id)
BM924285 pooled colon, kidney, stomach .a 109 to 1125 19 to 1051       1033/1137
(90 %)
33 diff
(97.1 %id)
BU183447 melanotic melanoma, cell line, skin .a 112 to 508 481 to 884       404/938
(43 %)
14 diff
(98.6 %id)
AW239120 lung, cell line .a 118 to 580 1 to 463       463/464
(99 %)
9 diff
(98.1 %id)
BF434168 fibrotheoma, ovary .a 120 to 650 13 to 543     Submitted on the opposite strand 531/531
(100 %)
1 diff
(99.9 %id)
BU855439 ovary, teratocarcinoma, cell line .a 125 to 1022 1 to 912       912/913
(99 %)
27 diff
(97.1 %id)
DA269612 caudate nucleus .a 127 to 688 2 to 564   capped   563/563
(100 %)
3 diff
(99.5 %id)
AK074733   .a 128 to 2132 1 to 2005   available from FLJ,   2005/2005
(100 %)
4 diff
(99.9 %id)
DA065764 cerebellum .a 128 to 696 2 to 570   capped   569/574
(99 %)
2 diff
(99.7 %id)
DA730551   .a 129 to 946 2 to 811   capped   810/840
(96 %)
12 diff
(98.6 %id)
AF289571   .a 134 to 2132 1 to 2009   AAA   2009/2009
(100 %)
16 diff
(99.3 %id)
BE258058 eye, retinoblastoma .a 136 to 797 1 to 655       655/690
(94 %)
15 diff
(97.9 %id)
DA713185   .a 138 to 604 2 to 469   capped   468/468
(100 %)
2 diff
(99.6 %id)
R57601   .a 141 to 467 1 to 325       325/325
(100 %)
7 diff
(97.9 %id)
BE280969 choriocarcinoma, placenta .a 147 to 765 1 to 620       620/621
(99 %)
4 diff
(99.4 %id)
BG778062 adenocarcinoma, Prostate .a 156 to 858 1 to 709       709/711
(99 %)
11 diff
(98.5 %id)
AA442801   .a 157 to 567 1 to 410       410/410
(100 %)
2 diff
(99.6 %id)
DB267506 uterus .a 158 to 741 2 to 585   capped   584/584
(100 %)
1 diff
(99.9 %id)
CR601006 T cells (Jurkat cell line) Cot10-normalized .a 161 to 2103 1 to 1943       1943/1943
(100 %)
0 diff
(100 %id)
AL558531 T cells from T cell leukemia .a 162 to 1236 1 to 1058       1058/1072
(98 %)
34 diff
(96.9 %id)
TI_57152104   .a 888 to 1643 29 to 791       763/923
(82 %)
22 diff
(97.7 %id)
AK300594   Gene SPRYD4, variant not shown         Suspected internal deletion, this clone was ignored    
BG763421 melanotic melanoma, high MDR (cell line), skin Gene SPRYD4, variant not shown         This clone was ignored    
DC384479   Gene SPRYD4, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA Expression Tissue Function, regulation, related genes C